Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Link opens in a new tab
Search content at OSU Center for Health Sciences Research Profiles
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Identifying Key Variables in AUD Multisite Trials: A Systematic Review
Alexander W. Douglas
,
Elizabeth P. Garrett
, S.S. O'Malley
, A.P. Aldridge
,
Matt Vassar
COM Entering Class of 2020
Office of Medical Student Research
Research Opportunities
Psychiatry and Behavioral Sciences
Research output
:
Contribution to conference
›
Poster
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Identifying Key Variables in AUD Multisite Trials: A Systematic Review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Randomized Controlled Trial
100%
Design Features
100%
Multisite Trials
100%
Treatment Length
66%
Naltrexone
33%
Metaanalysis
33%
Meta-regression
33%
Exclusion Criteria
33%
Database Search
33%
PubMed
33%
MEDLINE
33%
Embase
33%
Pharmacotherapy
33%
Placebo Groups
33%
Trial Design
33%
Disulfiram
33%
Statistical Significance
33%
Cochrane
33%
Intraclass Correlation Coefficient
33%
English Language
33%
Analytic Approach
33%
Inclusion-exclusion
33%
Attrition
33%
Number of Sites
33%
Ovid
33%
Alcohol Use Disorder
33%
Missing Data
33%
Scopus
33%
Missing Imputation
33%
Quantitative Features
33%
Categorical Features
33%
Characteristics Approach
33%
Collection Length
33%
Design Analytics
33%
Design Characteristics
33%
Acamprosate
33%
Site Characteristics
33%
Outcome Model
33%
Mathematics
Statistics
100%
IQR
100%
Median
100%
Interquartile Range
100%
Statistical Significance
100%
Covariate
100%
Intraclass Correlation
100%
Trial Design
100%
Statistical Approach
100%
Placebo Group
100%
Arm Trial
100%
Neuroscience
Naltrexone
100%
Placebo
100%
Disulfiram
100%
Acamprosate
100%
Psychology
Systematic Review
100%
Study Design
100%
Intraclass Correlation
50%
Alcohol Use Disorder
50%
Medline
50%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Naltrexone
33%
Placebo
33%
Pharmacotherapy
33%
Disulfiram
33%
Acamprosate
33%
Biochemistry, Genetics and Molecular Biology
Acamprosate
25%